456
Views
12
CrossRef citations to date
0
Altmetric
Retina

Subchoroidal Release of VEGF and bFGF Produces Choroidal Neovascularization in Rabbit

, , , , , & show all
Pages 237-243 | Received 01 Feb 2016, Accepted 17 Aug 2016, Published online: 17 Oct 2016

References

  • National Eye Institute. Available at http://www.nei.nih.gov/.
  • Abselsalam, A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999;44:1–29.
  • Rattner A, Nathans J. Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci 2006;7:860–872.
  • Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002;99:14682–14687.
  • Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthal 2003;48:257–293.
  • Ryan SJ. Subretinal neovascularization: natural history of an experimental model. Arch Ophthal 1982;100:1804–1809.
  • Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci 1986;27:1644–1652.
  • Frank RN, Das A, Weber ML. A model of subretinal neovascularization in the pigmented rat. Curr Eye Res 1989;8:239–247.
  • Kiilgaard JF, Andersen MVN, Wiencke AK, Scherfig E, La Cour M, Tezel TH, et al. A new animal model of choroidal neovascularization. Acta Ophthalmol Scandinavica 2005;83:697–704.
  • Hsu HT, Goodnight R, Ryan SJ. Subretinal choroidal neovascularization as a response to penetrating retinal injury in the pigmented rabbit. Jpn J Ophthalmol 1989;33:358–366.
  • El Dirini AA, Ogden TE, Ryan SJ. Subretinal endophotocoagulation: a new model of subretinal neovascularization in the rabbit. Retina 1991;11:244–249.
  • Wong CG, Rich KA, Liaw LHL, Hsu HT, Berns MW. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr Eye Res 2001;22:140–147.
  • Erb MH, Sioulis CE, Kuppermann BD, Osann K, Wong CG. Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds. Curr Eye Res 2002;24:245–252.
  • Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445–450.
  • Aiello LP, Avert RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487.
  • Sivalingam A, Kinney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retiopathy. Arch Ophthalmol 1990;108:869–872.
  • Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelilial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996;122:393–403.
  • Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242–248.
  • Wong CG, Gum GG, Hagemann L, Marques L, Kuppermann BD, de Carvalho RP. Induction of choroidal neovascularization by sustained release of VEGF/bFGF in rabbits: angiographic characterization and histologic correlation on different patterns of the choroidal vascular response. Invest Ophthalmol Vis Sci 2005; 46e-abstract 1417.
  • Wong CG, Bruice TC, You TT. Experimental CNV after trans-scleral implantation of VEGF/bFGF-implant within the suprachoroidal space for defining potential long-term synergistic actions of ranibizumab (Lucentis) with small low cost molecules in ameliorating wet AMD. Invest Ophthalmol Vis Sci 2008; 49e-abstract 1372.
  • Rabin D, Bruice TC, You TT, Wong CG. Both edema and leakage are expressed and are separable in long-term experimental CNV via sustained simultaneous release of VEGF and bFGF within the suprachoroidal space through trans-scleral implantation of a delivery device. Invest Ophthalmol Vis Sci 2008; 49e-abstract 1374.
  • Chen L, Miyamura N, Ninomiya Y, Handa JT. Distribution of the collagen IV isoforms in human Bruch’s membrane. Br J Ophthalmol 2003;87:212–215.; 83:141–152.
  • Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998;141:1659–1673.
  • Sylvie J, Kreppel F, Beck S, Heiduschka P, Brito V, Schnichels S, et al. A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit. Molecular Vis 2008;14:1358–1372.
  • Ni M, Holland M, Jarstadmarken H, DeVries G. Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation. Exp Eye Res 2005;8:286–297.
  • Qiu G, Stewart JM, Sadda S, Freda R, Lee S, Guven D, et al. A new model of experimental subretinal neovascularization in the rabbit. Exp Eye Res 2006;83:141–152.
  • Zahn G, Vossmeyer D, Stragies R, Wills M, Wong CG, Löffler KU, et al. Pre-clinical evaluation of the novel small-molecule integrin α5β1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization. Arch Ophthalmol 2009;127:1329–1335.
  • Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev 2001;52:37–48.
  • Kim SH, Lutz RJ, Wang NS, Robinson MR. Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res 2007;39:244–254.
  • Barocas VH, Balachandran RK. Sustained transscleral drug delivery. Expert Opin Drug Deliv 2008;5:1–10.
  • Pearce W, Hsu J, Yeh S. Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol 2015;26:233–239.
  • Patel RS, Lin ASP, Edelhauser HF, Rausnitz MR. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res 2011;28:166–176.
  • Lambrou FH, Chilbert M, Mieler WF, Williams GA, Olsen KA. New technique for subchoroidal implantation of experimental malignant melanoma. Invest Ophthal Vis Sci 1988;29:995–998.
  • Rabin DL, Rabin RL, Blenkinsop TA, Temple S, Stern JH. Chronic oxidative stress upregulates drusen‐related protein expression in adult human RPE stem cell‐derived RPE cells: A novel culture model for dry AMD. Aging 2013;5:51–66.
  • Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol 2013;13:438–451.
  • Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012;33:295–317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.